A new nasal spray therapy by Texas A&M researchers shows promise in delaying Alzheimer’s progression by targeting brain ...
Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling hope it could one day work in humans.
Investor's Business Daily on MSN2d
ARS Pharma Jumps After Inking $145 Million Deal For Epinephrine Nasal SprayARS Pharmaceuticals shares jumped Monday after the company inked a deal to commercialize its allergic reaction nasal spray internationally.
ALK-Abelló has acquired rights to Neffy adrenaline nasal spray in Europe and Canada, amongst other countries, from ARS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback